ClinicalTrials.Veeva

Menu
D

DermResearch, Inc. | Austin, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

PEP005
Adapalene
Tazarotene
Ruxolitinib
Ingenol Mebutate
AN2690
IDP-107
ALA
NAFT-600
122-0551

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 76 total trials

A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita (VAPAUS)

This study evaluates the safety and efficacy of QTORIN 3.9% rapamycin anhydrous gel in the treatment of adults with Pachyonychia Congenita. This stud...

Enrolling
Pachyonychia Congenita
Drug: Vehicle
Drug: QTORIN 3.9% rapamycin anhydrous gel
Locations recently updated

The masseter muscle is one of the muscles in the lower face used for chewing. The prominence of the masseter muscle can appear as a widened lower fac...

Enrolling
Masseter Muscle Prominence
Drug: Placebo
Drug: BOTOX

The purpose of this study is to evaluate the safety and tolerability of Ruxolitinib cream in participants with Prurigo Nodularis (PN).

Enrolling
Prurigo Nodularis
Drug: Ruxolitinib Cream
Drug: Vehicle Cream
Locations recently updated

This study is being conducted to determine the safety and tolerability of ruxolitinib 1.5% cream under maximal use conditions in participants with Pr...

Enrolling
Prurigo Nodularis
Drug: Ruxolitinib Cream 1.5%

This is a Phase 3 multicenter, double-blind study to evaluate the safety and efficacy of vehicle-controlled topical MOB015B in the treatment of Dista...

Active, not recruiting
Onychomycosis
Drug: MOB015B
Drug: Vehicle (Placebo Comparator)

The study is designed to validate safety results from the Phase 1 PP405-001 trial while also characterizing longer term safety and PK following 28 da...

Enrolling
Androgenetic Alopecia
Drug: PP405 Topical Vehicle Gel
Drug: PP405 0.05% Topical Gel

The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of one or two intramuscular injections of the Acne mRNA vaccine candi...

Enrolling
Acne
Biological: Acne mRNA vaccine
Other: Placebo

Trial sponsors

Galderma logo
D
P
Allergan logo
D
Pfizer logo
S
T
C
Incyte logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems